Communities across Asia's Himalayan Hindu Kush region face heightened disaster risks this monsoon season with temperatures ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Wildlife rescue teams scoured Australia's east coast on Monday to find and free a distressed humpback whale tangled in a rope ...

Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for the drugs, which often retail at more than $1,000 ...

If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the ...

Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

The FDA approved Zepbound to treat moderate to severe OSA in adults with obesity. The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to ...

The approval was based on data from the double-blind, phase 3 SURMOUNT-OSA study. The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe ...

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...

27 to treat sleep apnea ... attention and ignited a debate about access and demand for the drugs, which help people shave pounds. The FDA first approved Zepbound to treat obesity in November ...